Lv11
18 积分 2025-01-15 加入
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
3小时前
已完结
Pharmacokinetic considerations and strategies for antibody-based therapeutics
14天前
已完结
The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells
20天前
已完结
Glypicans as Cancer Therapeutic Targets
20天前
已完结
JoVE Video Dataset
1个月前
已关闭
Lipid Nanoparticle-Mediated Systemic RNA Delivery to the Spleen: Strategies, Applications, and Challenges
1个月前
已完结
In vitro models for immunogenicity prediction of therapeutic proteins
2个月前
已完结
A Reduction in B, T, and Natural Killer Cells Expressing CD38 by TAK-079 Inhibits the Induction and Progression of Collagen-Induced Arthritis in Cynomolgus Monkeys
2个月前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
2个月前
已完结
pH-dependent antigen-binding antibodies as a novel therapeutic modality
3个月前
已完结
皖公网安备34019202002308
